Evaluating Alcohol Use in Alcoholic Liver Disease



Status:Recruiting
Conditions:Gastrointestinal
Therapuetic Areas:Gastroenterology
Healthy:No
Age Range:18 - 80
Updated:3/15/2019
Start Date:November 27, 2016
End Date:November 1, 2027
Contact:Nicole T Shen, MD
Email:nts9004@nyp.org
Phone:3146095911

Use our guide to learn which trials are right for you!

This prospective, analytic observational study will investigate alcohol recidivism in
patients with alcoholic liver disease. All adult subjects presenting with alcoholic liver
disease are considered for inclusion. Subjects able to give consent are included.

This is a longitudinal observational study. Subjects with a diagnosis of alcoholic liver
disease (acute alcoholic hepatitis or alcoholic cirrhosis) who present to Weill Cornell
Medical Center or Columbia University Medical Center New York Presbyterian Hospital or the
Gastroenterology and Hepatology Clinic will be invited to join this study, which entails a
survey at baseline and follow-up at 3, 6, 9, 12, 15, and 18 months and then at 2, 5, and 10
years. Follow-up will consist of a chart review, a phone or in person interview, and most
recent clinic visit interview for alcohol recidivism. The clinical providers will be blinded
to the survey results.

Inclusion Criteria:

- alcoholic liver disease able to consent

Exclusion Criteria:

- without alcoholic liver disease unable to consent
We found this trial at
1
site
630 West 168th Street
New York, New York 10021
Phone: 314-609-5911
?
mi
from
New York, NY
Click here to add this to my saved trials